Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2025

May 2, 2025

284_dirs_2025-05-02_307ee92f-098a-4661-9962-b54f185a091b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-04-30

Reporting Person: Smart Dalton E. III (SVP Fin. - Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-04-30 Common Stock M 464 $84.71 Acquired 8241.802 Direct
2025-04-30 Common Stock F 159 $84.71 Disposed 8082.802 Direct
2025-05-02 Common Stock M 381 $83.26 Acquired 8463.802 Direct
2025-05-02 Common Stock F 131 $83.26 Disposed 8332.802 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-04-30 Restricted Stock Unit $ M 464 Disposed 2027-04-30 Common Stock (464) Direct
2025-05-02 Restricted Stock Unit $ M 381 Disposed 2026-05-02 Common Stock (381) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.